| # | Title | Type | Source | Description |
|---|---|---|---|---|
| 1 | FDA Extends MoCRA Enforcement Deadline: Cosmetics Industry Gets Additional 6 Months | Regulatory Regions | gpcgateway.com | ecember 2023. Details of the Delayed Enforcement: The FDA's decision to |
| 2 | EU represented by Oeko-Institut consults on lead exemption for medical devices | Regulatory Regions | gpcgateway.com | lead-free alternatives, which have been delayed due to the COVID-19 pandemic. Rep |
| 3 | EFSA and ECHA assessment of glyphosate to be pushed back to mid-2023 | Regulatory Regions | gpcgateway.com | vironmental risks of glyphosate will be delayed. Glyphosate-based herbicides are the |
| 4 | India extends QCO Enforcement for three substances | Regulatory Regions | gpcgateway.com | hosphoric Acid (December 22, 2022). The delays, according to the DCPC, are due to a b |
| 5 | Latin America Forum Unveils Chemical Management Document Series | Regulatory Regions | gpcgateway.com | tories often bring duplication of data, delay trades, and increased expenses. The OEC |
| 6 | European Parliament votes to expand upcoming carbon tariffs to chemicals | Regulatory Regions | gpcgateway.com | to propose technical adjustments or the delay of the CBAM entry into force relative t |
| 7 | European Commission sketches timeline for adoption of key legislative proposals | Regulatory Regions | gpcgateway.com | enda. This could signal that it will be delayed and presented in 2023. This would |
| 8 | DEFRA consults on the extension of transitional registration deadlines under UK REACH | Regulatory Regions | gpcgateway.com | econd (and preferred) option would only delay these by 2 and 1 years (to October 2027 |
| 9 | NMPA published notification on optimizing cosmetic ingredients registration | Regulatory Regions | gpcgateway.com | ting ingredients safety information was delayed from 1 May 2023 to 1 January 2024. |
| 10 | Guidance Documents have been Translated into Turkish | Regulatory Regions | gpcgateway.com | es related to chemicals is made without delay by making use of the guidance documents |
| 11 | REACH revision further delayed - a "life and death” matter. | Regulatory Regions | gpcgateway.com | eeps on coming. The reform might now be delayed to 2024. The delay is particularly co |
| 12 | EU Proposes Simplified Taxonomy Reporting to Reduce Burden on Companies | Regulatory Regions | gpcgateway.com | related metrics, with some requirements delayed until 2027. Why These C |
| 13 | Sustainable Use of Pesticides: Updates on the Directive 2009/128/EC | Regulatory Regions | gpcgateway.com | y scheduled for 23 March 2022, has been delayed, reportedly, due to Russia's war on U |
| 14 | India delays Quality Control Orders for six chemicals to April 2023 | Regulatory Regions | gpcgateway.com | f Chemicals & Petrochemicals (DCPC) has delayed the implementation of the Quality Con |
| 15 | Implementation of QCO for ethylene glycol delayed in India | Regulatory Regions | gpcgateway.com | Chemicals and Petrochemicals (DCPC) has delayed the implementation of the quality con |
| 16 | India extends Quality Control Order Enforcement Date for 10 Substances on Two Occasions | Regulatory Regions | gpcgateway.com | ished two notices in the Indian Gazette delaying the start date for the Quality Contr |
| 17 | Guidelines for Sampling Cosmetics and Drugs Introduced in India | Regulatory Regions | gpcgateway.com | Timelines To avoid delays in testing and laboratory reports, it |
| 18 | European Ombudsman Criticises Delays in Managing Hazardous Chemicals Under REACH Regulation | Regulatory Regions | gpcgateway.com | g on the European Commission to address delays in the authorisation of dangerous chem |
| 19 | India delays Quality Control Order Enforcement Date for 3 Substances | Regulatory Regions | gpcgateway.com | ublished a notice in the Indian Gazette delaying the start date for the Quality Contr |
| 20 | FDA Issues Final Guidance for MoCRA Cosmetic Product Facility Registration and Listings | Regulatory Regions | gpcgateway.com | of such conditions of use. Delayed Enforcement The FDA will not enf |
If you want to access the GHS report, please Register here in GPC Intelligence Portal click here